These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26980168)

  • 21. Pharmacy program for improved handling of antineoplastic agents.
    Scott SA; Schrott DB; Loesch GA
    Am J Hosp Pharm; 1983 Jul; 40(7):1179-82. PubMed ID: 6881156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occupational exposure to anti-cancer drugs: A review of effects of new technology.
    Vyas N; Yiannakis D; Turner A; Sewell GJ
    J Oncol Pharm Pract; 2014 Aug; 20(4):278-87. PubMed ID: 23975555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to Precautionary Guidelines for Compounding Antineoplastic Drugs: A Survey of Nurses and Pharmacy Practitioners.
    Boiano JM; Steege AL; Sweeney MH
    J Occup Environ Hyg; 2015; 12(9):588-602. PubMed ID: 25897702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safe handling of antineoplastic drugs.
    Harrison BR
    Top Hosp Pharm Manage; 1994 Jul; 14(2):1-10. PubMed ID: 10136200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for handling cytotoxic drugs in hospitals.
    Stolar MH; Power LA; Viele CS
    Am J Hosp Pharm; 1983 Jul; 40(7):1163-71. PubMed ID: 6881154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of the cytostatic drugs unit in rationalization of hospital drugs management--the case study and the analysis of drug utilization].
    Zuziak S; Topór-Madry R; Pilc A; Bochenek T
    Pol Merkur Lekarski; 2014 Jul; 37(217):43-8. PubMed ID: 25154199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaporation of selected cytotoxic drugs and permeation of protective gloves--research into the occupational risks of health care personnel handling hazardous cytotoxic drugs (CYTO project)].
    Dolezalová L; Odráska P; Gorná L; Prudilová M; Vejpustková R; Bláha L
    Klin Onkol; 2009; 22(5):218-22. PubMed ID: 19886359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use and handling safety of Mini-Spike 2
    García SV; Clérigues NV; Ferrer VF; Briz EL; Andrés JLP
    Regul Toxicol Pharmacol; 2018 Dec; 100():1-6. PubMed ID: 30296468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safe procedure development to manage hazardous drugs in the workplace.
    Gaspar Carreño M; Achau Muñoz R; Torrico Martín F; Agún Gonzalez JJ; Sanchez Santos JC; Cercos Lletí AC; Ramos Orozco P
    Farm Hosp; 2017 Mar; 41(2):222-256. PubMed ID: 28236799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings.
    Sabatini L; Barbieri A; Lodi V; Violante FS
    Med Lav; 2012; 103(5):394-401. PubMed ID: 23077799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality-assurance testing of staff pharmacists handling cytotoxic agents.
    Harrison BR; Godefroid RJ; Kavanaugh EA
    Am J Health Syst Pharm; 1996 Feb; 53(4):402-7. PubMed ID: 8673660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing guidelines for working with antineoplastic drugs.
    Harrison BR
    Am J Hosp Pharm; 1981 Nov; 38(11):1686-93. PubMed ID: 7304620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations.
    Ashe K; Baskett D
    Int J Pharm Compd; 2018; 22(5):387-398. PubMed ID: 30384337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality assurance: ensuring pharmacy personnel follow procedures for handling cytotoxic drugs.
    Scott BE; White SJ; Matthews T
    Hosp Pharm; 1987 Jan; 22(1):45-9. PubMed ID: 10280293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a closed drug preparation method for oral anticancer drugs.
    Wakui N; Ookubo T; Iwasaki Y; Ito R; Saito K; Nakazawa H
    J Oncol Pharm Pract; 2013 Dec; 19(4):315-20. PubMed ID: 23292970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.
    Hon CY; Teschke K; Demers PA; Venners S
    Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technical considerations in the preparation and dispensing of chemotherapy.
    Peters BG
    Top Hosp Pharm Manage; 1995 Jan; 14(4):78-88. PubMed ID: 10140430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a closed-system cytotoxic transfer device in a pharmaceutical isolator.
    Vyas N; Turner A; Clark JM; Sewell GJ
    J Oncol Pharm Pract; 2016 Feb; 22(1):10-9. PubMed ID: 25073678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Continuous training program for technicians handling antineoplastic drugs and occupational exposure risk].
    Dussart C; Favier B; Gilles L; Camal I; Almeras D; Latour JF; Grelaud G
    Bull Cancer; 2008 Sep; 95(9):821-2. PubMed ID: 18829414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of drug contamination levels in an admixture preparation area.
    Christenson I; Jansson B
    J Clin Hosp Pharm; 1983 Sep; 8(3):241-5. PubMed ID: 6313768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.